BioNTech Insider Trades
NASDAQ: BNTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 24 · $81.51M
- Shares bought / sold
- 0 / 821.00K
- Net activity
- Net selling $81.5 million
BioNTech insider activity
Over the last 12 months, BioNTech insiders reported 24 transactions on SEC Form 4: 0 open-market purchases and 24 sales. Insiders bought $0 and sold $81.5 million worth of stock, for net insider selling of $81.5 million. The largest seller was Sahin Ugur, with $76.0 million in reported sales.
The most recent filing shows Sahin Ugur (Chief Executive Officer) selling 21,000 shares at $96.81 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BNTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BNTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Sahin UgurChief Executive Officer | Sale | 21,000 | $2.03M | Form 4 |
| Oct 5, 2026 | Sahin UgurChief Executive Officer | Sale | 72,000 | $7.00M | Form 4 |
| Oct 2, 2026 | Sahin UgurChief Executive Officer | Sale | 17,000 | $1.64M | Form 4 |
| Oct 1, 2026 | Sahin UgurChief Executive Officer | Sale | 17,000 | $1.66M | Form 4 |
| Sep 30, 2026 | Sahin UgurChief Executive Officer | Sale | 32,000 | $3.14M | Form 4 |
| Sep 29, 2026 | Sahin UgurChief Executive Officer | Sale | 34,000 | $3.34M | Form 4 |
| Sep 28, 2026 | Sahin UgurChief Executive Officer | Sale | 34,000 | $3.35M | Form 4 |
| Sep 25, 2026 | Sahin UgurChief Executive Officer | Sale | 27,000 | $2.66M | Form 4 |
| Sep 24, 2026 | Sahin UgurChief Executive Officer | Sale | 39,000 | $3.86M | Form 4 |
| Sep 23, 2026 | Sahin UgurChief Executive Officer | Sale | 30,000 | $2.98M | Form 4 |
| Sep 22, 2026 | Sahin UgurChief Executive Officer | Sale | 46,000 | $4.63M | Form 4 |
| Sep 21, 2026 | Sahin UgurChief Executive Officer | Sale | 33,000 | $3.23M | Form 4 |
| Sep 18, 2026 | Sahin UgurChief Executive Officer | Sale | 30,000 | $2.89M | Form 4 |
| Sep 17, 2026 | Sahin UgurChief Executive Officer | Sale | 34,000 | $3.35M | Form 4 |
| Sep 16, 2026 | Sahin UgurChief Executive Officer | Sale | 15,000 | $1.44M | Form 4 |
| Sep 15, 2026 | Sahin UgurChief Executive Officer | Sale | 34,000 | $3.28M | Form 4 |
| Sep 14, 2026 | Sahin UgurChief Executive Officer | Sale | 41,000 | $4.08M | Form 4 |
| Sep 11, 2026 | Sahin UgurChief Executive Officer | Sale | 45,000 | $4.36M | Form 4 |
| Sep 10, 2026 | Sahin UgurChief Executive Officer | Sale | 20,500 | $1.97M | Form 4 |
| Sep 9, 2026 | Sahin UgurChief Executive Officer | Sale | 36,000 | $3.52M | Form 4 |
| Sep 8, 2026 | Sahin UgurChief Executive Officer | Sale | 37,000 | $3.67M | Form 4 |
| Sep 4, 2026 | Sahin UgurChief Executive Officer | Sale | 31,500 | $3.26M | Form 4 |
| Sep 3, 2026 | Sahin UgurChief Executive Officer | Sale | 45,000 | $4.63M | Form 4 |
| Apr 22, 2026 | Poetting SierkChief Operating Officer | Sale | 50,000 | $5.53M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4